{"DataElement":{"publicId":"14510658","version":"1","preferredName":"Prior Chemotherapy Temozolomide Administered Completion Date","preferredDefinition":"The date when prior treatment with temozolomide was complete.","longName":"3913803v1.00:3113414v1.00","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"3913803","version":"1","preferredName":"Prior Chemotherapy Temozolomide Administered","preferredDefinition":"Previous chemotherapy administered as treatment for this cancer._A triazene analog of dacarbazine with antineoplastic activity.  As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of  DNA replication.  Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04)_The act of having given something (e.g., a medication or test).","longName":"3654832v1.0:3913801v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"3654832","version":"1","preferredName":"Prior Chemotherapy","preferredDefinition":"Previous chemotherapy administered as treatment for this cancer.","longName":"C16171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior Chemotherapy","conceptCode":"C16171","definition":"Previous chemotherapy administered as treatment for this cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D40CB30D-C9B2-674C-E040-BB89AD435C4D","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3913801","version":"1","preferredName":"Temozolomide Administered","preferredDefinition":"A triazene analog of dacarbazine with antineoplastic activity.  As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of  DNA replication.  Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04):The act of having given something (e.g., a medication or test).","longName":"C1244:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Temozolomide","conceptCode":"C1244","definition":"A triazene analog of dacarbazine with antineoplastic activity.  As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of DNA replication. Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D5C0C6-F06C-DBFF-E040-BB89AD432659","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"ONEDATA","dateModified":"2013-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D5C0C6-F07D-DBFF-E040-BB89AD432659","latestVersionIndicator":"Yes","beginDate":"2013-10-03","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2013-10-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3113414","version":"1","preferredName":"Completion Date","preferredDefinition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)_a particular day specified as the time something has, or will, happen.","longName":"COMPL_DT","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":null,"format":"mm/dd/yy","PermissibleValues":[],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2436883","version":"1","preferredName":"Complete Date","preferredDefinition":"Complete; having every necessary or normal part or component or step; or having come or been brought to a conclusion.:a particular day specified as the time something has, or will, happen.","longName":"C25250:C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07CFEE0B-AFA0-3396-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-12-13","modifiedBy":"ONEDATA","dateModified":"2005-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MMQL: Minneapolis-Manchester QOL Survey of Health","workflowStatus":"RELEASED","registrationStatus":"Application","id":"89A31591-6CF3-AE55-E040-BB89AD432CE8","latestVersionIndicator":"Yes","beginDate":"2010-06-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-06-22","modifiedBy":"COOPERM","dateModified":"2010-08-31","changeDescription":"6/22/10 Created for MMQL data element. mc 8/31/2010 released VD per D. Reeves request. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Temozolomide completion date","url":null,"context":"Alliance"},{"name":"Alliance Text 1","type":"Alternate Question Text","description":"If Yes, Temozolomide Completion Date","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06621464-4B55-57E4-E063-731AD00AA3CE","latestVersionIndicator":"Yes","beginDate":"2023-09-27","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-27","modifiedBy":"ZHWENDY","dateModified":"2023-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}